logo

Latest Financial Updates

Read latest financial news update from our blog

Cramer: Why the rally in bank stocks is great for the entire market — and far from over
Cramer: Why the rally in bank stocks is great for the entire market — and far from over

Something unpredictable happened last week that is so positive I almost hesitate to write...

Admin | Finance | 2 months ago

Ardene Canada Sale: Save 50% off Boots + More - Hot Canada Deals
Ardene Canada Sale: Save 50% off Boots + More - Hot Canada Deals

Ardene Canada has great offers available now. This sale is valid until December 11, 2023....

Admin | Finance | 2 months ago

Macy's gets $5.8B offer to be taken private - WSJ (NYSE:M)
Macy's gets $5.8B offer to be taken private - WSJ (NYSE:M)

A private equity group has made a $5.8B offer to take Macy's private. The offer from Arkh...

Admin | Finance | 2 months ago

Michelle Mone admits ‘error’ in denying links to PPE firm
Michelle Mone admits ‘error’ in denying links to PPE firm

Baroness Michelle Mone has conceded she made an “error” in publicly denying her links to t...

Admin | Finance | 2 months ago

Qulo Games
Qulo Games

Admin | Finance | 2 months ago

Josh Hawley blasts GOP leaders after a measure compensating victims exposed to nuclear waste radiation was stripped from the latest defense bill: 'A betrayal'
Josh Hawley blasts GOP leaders after a measure compensating victims exposed to nuclear waste radiation was stripped from the latest defense bill: 'A betrayal'

Josh Hawley is a cosponsor of a radiation compensation reauthorization measure on Capitol...

Admin | Finance | 2 months ago

USD/JPY: Solid jobs report, reduced expectations of Fed cut, BOJ pivot, underpinning pair
USD/JPY: Solid jobs report, reduced expectations of Fed cut, BOJ pivot, underpinning pair

A couple of items from Friday to take note of for USD/JPY traders. 1. Expectations of Fed...

Admin | Finance | 2 months ago

Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease
Incyte and Syndax Present Additional Data from Positive AGAVE-201 Trial at ASH Plenary Session Showing Axatilimab Efficacy Including Durable Responses in Chronic Graft-Versus-Host Disease

This advertisement has not loaded yet, but your article continues below. Incyte and Synda...

Admin | Finance | 2 months ago

Join Our Newsletter

join our newsletter to receive update from us